3.16
price up icon1.94%   0.06
pre-market  Vorhandelsmarkt:  3.22   0.06   +1.90%
loading

Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 0.21
Research and Development
22.02%
1.646
1.349 - - -
Costs And Expenses
3.93%
3.467
3.609 3.051 2.844 2.77
Operating Income/Loss
3.93%
-3.467
-3.609 -3.051 -2.844 -2.56
Income/Loss From Continuing Operations Before Tax
3.34%
-3.18
-3.29 -2.721 -2.548 -2.307
Income/Loss From Continuing Operations After Tax
3.34%
-3.18
-3.29 -2.721 -2.548 -2.307
Net Income/Loss
3.34%
-3.18
-3.29 -2.721 -2.548 -2.307
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
17.14%
-0.041
-0.035 -0.031 -0.037 -0.019
Basic Average Shares
1.49%
0.0319
0.0314 0.000039 0.031 -
Diluted Average Shares
1.49%
0.0319
0.0314 0.000039 0.031 0.0309
Basic Earnings Per Share
200.00%
-0.10
0.10 0.55 -0.08 -0.07
Diluted Earnings Per Share
200.00%
-0.10
0.10 0.55 -0.08 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.55
price up icon 0.23%
$37.12
price down icon 0.40%
$105.18
price up icon 0.17%
$26.66
price down icon 0.30%
$110.05
price down icon 1.28%
biotechnology ONC
$299.94
price down icon 1.90%
Kapitalisierung:     |  Volumen (24h):